A detailed history of Client First Investment Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Client First Investment Management LLC holds 2,453 shares of LLY stock, worth $1.84 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
2,453
Previous 2,449 0.16%
Holding current value
$1.84 Million
Previous $2.22 Billion 2.01%
% of portfolio
1.66%
Previous 1.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $3,088 - $3,840
4 Added 0.16%
2,453 $2.17 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $2,174 - $2,727
3 Added 0.12%
2,449 $2.22 Billion
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 0.2%
2,446 $1.9 Billion
Q4 2023

Apr 10, 2024

BUY
$525.19 - $619.13 $1.28 Million - $1.51 Million
2,441 New
2,441 $1.42 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Client First Investment Management LLC Portfolio

Follow Client First Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Client First Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Client First Investment Management LLC with notifications on news.